Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer

Robert W. Veltri, Christhunesa S. Christudass

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Nuclear structure alterations in cancer involve global genetic (mutations, amplifications, copy number variations, translocations, etc.) and epigenetic (DNA methylation and histone modifications) events that dramatically and dynamically spatially change chromatin, nuclear body, and chromosome organization. In prostate cancer (CaP) there appears to be early (60 years) onset clinically significant cancers, and we have yet to clearly understand the hereditary and somatic-based molecular pathways involved. We do know that once cancer is initiated, dedifferentiation of the prostate gland occurs with significant changes in nuclear structure driven by numerous genetic and epigenetic processes. This review focuses upon the nuclear architecture and epigenetic dynamics with potential translational clinically relevant applications to CaP. Further, the review correlates changes in the cancer-driven epigenetic process at the molecular level and correlates these alterations to nuclear morphological quantitative measurements. Finally, we address how we can best utilize this knowledge to improve the efficacy of personalized treatment of cancer.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages77-99
Number of pages23
Volume773
ISBN (Print)9781489980311
DOIs
StatePublished - 2014

Publication series

NameAdvances in Experimental Medicine and Biology
Volume773
ISSN (Print)00652598

Fingerprint

Epigenomics
Prostatic Neoplasms
Genetic Epigenesis
Chromosomes
Histones
Chromatin
Amplification
Neoplasms
Histone Code
Genetic Phenomena
DNA Methylation
Prostate
Mutation

Keywords

  • Epigenetics
  • Nuclear morphology
  • Nuclear roundness
  • Prostate cancer

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Veltri, R. W., & Christudass, C. S. (2014). Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer. In Advances in Experimental Medicine and Biology (Vol. 773, pp. 77-99). (Advances in Experimental Medicine and Biology; Vol. 773). Springer New York LLC. https://doi.org/10.1007/978-1-4899-8032-8_4

Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer. / Veltri, Robert W.; Christudass, Christhunesa S.

Advances in Experimental Medicine and Biology. Vol. 773 Springer New York LLC, 2014. p. 77-99 (Advances in Experimental Medicine and Biology; Vol. 773).

Research output: Chapter in Book/Report/Conference proceedingChapter

Veltri, RW & Christudass, CS 2014, Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer. in Advances in Experimental Medicine and Biology. vol. 773, Advances in Experimental Medicine and Biology, vol. 773, Springer New York LLC, pp. 77-99. https://doi.org/10.1007/978-1-4899-8032-8_4
Veltri RW, Christudass CS. Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer. In Advances in Experimental Medicine and Biology. Vol. 773. Springer New York LLC. 2014. p. 77-99. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4899-8032-8_4
Veltri, Robert W. ; Christudass, Christhunesa S. / Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer. Advances in Experimental Medicine and Biology. Vol. 773 Springer New York LLC, 2014. pp. 77-99 (Advances in Experimental Medicine and Biology).
@inbook{1eebe5fc00ec442d9d8571fa474cc9ed,
title = "Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer",
abstract = "Nuclear structure alterations in cancer involve global genetic (mutations, amplifications, copy number variations, translocations, etc.) and epigenetic (DNA methylation and histone modifications) events that dramatically and dynamically spatially change chromatin, nuclear body, and chromosome organization. In prostate cancer (CaP) there appears to be early (60 years) onset clinically significant cancers, and we have yet to clearly understand the hereditary and somatic-based molecular pathways involved. We do know that once cancer is initiated, dedifferentiation of the prostate gland occurs with significant changes in nuclear structure driven by numerous genetic and epigenetic processes. This review focuses upon the nuclear architecture and epigenetic dynamics with potential translational clinically relevant applications to CaP. Further, the review correlates changes in the cancer-driven epigenetic process at the molecular level and correlates these alterations to nuclear morphological quantitative measurements. Finally, we address how we can best utilize this knowledge to improve the efficacy of personalized treatment of cancer.",
keywords = "Epigenetics, Nuclear morphology, Nuclear roundness, Prostate cancer",
author = "Veltri, {Robert W.} and Christudass, {Christhunesa S.}",
year = "2014",
doi = "10.1007/978-1-4899-8032-8_4",
language = "English (US)",
isbn = "9781489980311",
volume = "773",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "77--99",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer

AU - Veltri, Robert W.

AU - Christudass, Christhunesa S.

PY - 2014

Y1 - 2014

N2 - Nuclear structure alterations in cancer involve global genetic (mutations, amplifications, copy number variations, translocations, etc.) and epigenetic (DNA methylation and histone modifications) events that dramatically and dynamically spatially change chromatin, nuclear body, and chromosome organization. In prostate cancer (CaP) there appears to be early (60 years) onset clinically significant cancers, and we have yet to clearly understand the hereditary and somatic-based molecular pathways involved. We do know that once cancer is initiated, dedifferentiation of the prostate gland occurs with significant changes in nuclear structure driven by numerous genetic and epigenetic processes. This review focuses upon the nuclear architecture and epigenetic dynamics with potential translational clinically relevant applications to CaP. Further, the review correlates changes in the cancer-driven epigenetic process at the molecular level and correlates these alterations to nuclear morphological quantitative measurements. Finally, we address how we can best utilize this knowledge to improve the efficacy of personalized treatment of cancer.

AB - Nuclear structure alterations in cancer involve global genetic (mutations, amplifications, copy number variations, translocations, etc.) and epigenetic (DNA methylation and histone modifications) events that dramatically and dynamically spatially change chromatin, nuclear body, and chromosome organization. In prostate cancer (CaP) there appears to be early (60 years) onset clinically significant cancers, and we have yet to clearly understand the hereditary and somatic-based molecular pathways involved. We do know that once cancer is initiated, dedifferentiation of the prostate gland occurs with significant changes in nuclear structure driven by numerous genetic and epigenetic processes. This review focuses upon the nuclear architecture and epigenetic dynamics with potential translational clinically relevant applications to CaP. Further, the review correlates changes in the cancer-driven epigenetic process at the molecular level and correlates these alterations to nuclear morphological quantitative measurements. Finally, we address how we can best utilize this knowledge to improve the efficacy of personalized treatment of cancer.

KW - Epigenetics

KW - Nuclear morphology

KW - Nuclear roundness

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84934434358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934434358&partnerID=8YFLogxK

U2 - 10.1007/978-1-4899-8032-8_4

DO - 10.1007/978-1-4899-8032-8_4

M3 - Chapter

C2 - 24563344

AN - SCOPUS:84934434358

SN - 9781489980311

VL - 773

T3 - Advances in Experimental Medicine and Biology

SP - 77

EP - 99

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -